Posted inStock
Pfizer Stock Gains to $27.45 as Institutional Activity and Oncology Pipeline Drive Sentiment
Pfizer (NYSE: PFE) moved higher to $27.45, up 0.49%, outperforming a broader market selloff where major tech stocks declined sharply. The stockâs resilience reflects a combination of defensive demand, institutional…







